GALAPAGOS PARTNERS SELECT EQUITY FUND (US90386H8189) Jyseleca growth stalls...
Galapagos reported its Q1 2023 results with Jyseleca coming in 14% below consensus at EUR 26.7m (Q4 2022: EUR 27.1m) as last year\'s unfavorable EMA PRAC review is putting pressure on JAK inhibitors....
View Article
More Pages to Explore .....